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Administration of 
drugs to patients with 
swallowing difficulties
Patients who are unable to swallow due to a debilitating condition 
become dependant on an enteral feeding tube both for nutritional 
needs and for administration of medicines. In general medicines are 
unlicensed for use in enteral tubes, due to the specialist area and due 
to the limiting licence conditions.1  Information regarding this mode 
of administration is very scarce and also associated with increased 
risk of tube obstruction, increased toxicity and reduced efficacy due to 
an inadequate administration method.2  It must be kept in mind that 
any instructions regarding the administration and cautions of an oral 
dosage formulation also apply when one considers administering the 
medicine down an enteral feeding tube. Possibly the enteral feeding 
tube must be used as the last option for administering medicines.
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Introduction
This article aims to highlight a few 
issues which one encounters when advising 
about how best to administer a medicine to 
a patient who cannot swallow or who has an 
enteral feeding tube.
The British Association for Parenteral 
and Enteral Nutrition (BAPEN) established 
a multi professional working group in early 
2002 led by the British Pharmaceutical 
Nutrition Group (BPNG) to develop 
information resources on this subject.  
In 2003 BAPEN launched Guidance on 
administering drugs via enteral feeding 
tubes which brings together a concise 
compilation of information regarding 
techniques in this mode of administration 
in a concise way.1 
Unfortunately, crushing tablets is 
mistakenly taken for granted by some 
healthcare professionals without considering 
that the properties of the medication may 
be affected. As a result of this practice, 
the treatment may not be effective and 
may actually cause toxicity and in extreme 
cases fatality has occurred – eg. A fatality 
occurred from administration of labetalol 
and crushed extended-release nifedipine 
because the sustained release property of 
nifedipine was broken down and therefore 
affected its bioavailability.3
Alternative	routes
When patients are on multi drug 
regimens and then are suddenly switched 
to an enteral route, the treatment needs 
to be revised and the necessity of each 
medication evaluated for temporary 
discontinuation or changed to an 
alternative route such as an injection.  
Consideration could also be made to change 
a medicine to a different drug which has the 
same pharmacological effects but would be 
available in an alternative route to oral. 
When changing formulations, dose 
equivalencies need to be taken into account 
eg. phenytoin, digoxin and fusidic acid.  
1g of sodium fusidate is approximately 
equivalent to 0.98g of fusidic acid, 
therefore doses of fusidic acid suspension 
appear relatively higher.4  Carbamazepine 
suppositories need to be adjusted to be 
equivalent to the oral dose.   Therefore 
dosage or frequency adjustments may be 
necessary when changing administration 
routes especially from one agent to 
another.2   Avoid changing the brand of the 
product used since formulations of the same 
drug may vary between manufacturers.5
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Issues	with	liquid	formulations
Liquids, soluble or dispersible 
tablets are the preferred formulation for 
administration via feeding tubes however 
not all liquids are suitable for use in 
enteral tubes.4,6  They may be too viscous 
for administration via this route and may 
also be associated with ‘bezoars’ which 
consist of indigestible concretions which 
may form in the stomach of patients with 
impaired gastric emptying.  Some liquids 
are not recommended for enteral tube 
administration because they are absorbed 
or bound to the plastic tubing eg. diazepam 
liquid and phenytoin liquid.6
The excipients in liquids also need to be 
considered for their side effects when given 
enterally.  Many sweeteners cause or worsen 
diarrhea, however sorbitol most commonly 
causes GI problems.2  Cumulative sorbitol 
doses of 7.5 to 30g may cause adverse 
effects, with symptoms being particularly 
severe above 20g.6  The content of sorbitol 
varies depending on the manufacturer and 
the concentration of the preparation.  Care 
must be taken as to the volumes used 
and the fact that a patient may be taking 
multiple liquids which may lead to large 
concentrations of sorbitol and therefore 
increase the possibility of associated side 
effects.    
Osmolality of liquids is also associated 
with GI adverse effects such as diarrhoea.  
Many liquids have an osmolality higher 
than 1000mOsm/kg which is much higher 
than the osmolality of GI secretions (100-
400mOsm/kg).  However the osmolality 
data of many liquids is not readily available. 
These adverse effects may be avoided by 
diluting the liquid although this procedure 
cannot be generally recommended due 
to the manufacturer warning against 
its dilution and due to lack of stability 
information.
Although not all elixirs and suspensions 
are recommended for administration via 
an enteral feeding tube (some may cause 
clogging), they are generally preferable to 
syrups since the latter have an acidic pH 
and ‘clump’ when in contact with enteral 
feeds.
Issues	with	oral	solid	
dosage	forms
When an alternative route is not 
possible and liquid preparations are not 
available, solid oral dosage forms including 
tablets and capsules is usually considered.  
However one must be aware that generally 
an unlicensed use of the medicine is 
occurring and that the responsibility lies 
with the prescriber, dispenser and/or person 
responsible for providing or administering 
the drug.7 Crushed tablets are the most 
frequent cause of obstruction of feeding 
tubes which results in increased morbidity 
and trauma to the patient besides the cost 
of replacing the tube.8  This may require 
surgical intervention.6  
Tables 1 and 2 below give examples of 
preparations that should not be crushed.  
However the  properties of the drug must 
be also considered, such as light sensitivity 
or water sensitivity which would be a major 
contributory factor in the degradation 
of the drug during the crushing process.  
Medications may be offensive-tasting and 
may cause irritation of the oral mucosa 
or gastric lining if crushed and therefore 
consideration has to be given to the site of 
entry ie. directly into the buccal cavity or 
via a nasogastric tube.
The same principles are true when 
considering splitting tablets.  As a general 
rule tablets which are not scored, should 
not be split, let alone crushed.  If a tablet 
is scored, then it is usually considered 
by the manufacturer to be suitable for 
division, although this may still be a 
problem if the tablet does not break evenly 
into equal sizes.9 The halved tablet is then 
exposed and therefore stability cannot be 
guaranteed.
The same reasoning holds for opening 
capsules where the powder may be light-
sensitive eg. nifedipine or irritant eg. 
doxycycline hydrate.  Some capsules contain 
enteric-coated granules which should 
not be crushed eg. omeprazole, however 
controversial methods exist of how such 
granules may be administered via an enteral 
feeding tube.
Drug-feed	interactions
Besides problems associated with 
the formulation of the drug, other 
problems include the correct timing of 
drug administration in relation to feeding 
times and the importance of flushing the 
feeding tube before and after each drug 
administration in order to prevent drug-
nutrition incompatibilities.8   Generally, if 
the absorption of a medicine is affected 
by food, the same will happen with enteral 
feeds.  Avoiding drug interactions is 
largely dependent on whether the feed 
is being administered in an intermittent 
Unscored tablets
Unusually thick or oddly shaped tablets
Film and sugar coated tablets
Enteric or protective coated tablets
Sustained release preparations
Sustained release granules eg. omeprazole
Microencapsulated products
Buccal or sublingual preparations
Chewable tablets
Bitter tasting
Table	1:	Formulations	that	should	
not	be	crushed	or	opened	2,7,9,10,11,12
Antibiotics
Drugs with teratogenic, carcinogenic or cytotoxic properties such as antineoplastics
Teratogenic or Carcinogenic drugs
Nitrates
Steroids
Pancreatic enzymes
Hormone preparations
Prostaglandin analogues
Irritant drugs; also corrosive to oral mucosa and GI tract.
Staining oral mucosa and teeth
Drugs causing allergic reactions
Cross contamination is also possible from the crushing device
Table	2:	Classes	of	drugs	that	should	not	be	crushed	or	opened	2,7,9,10,11,12
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or continuous regimen and how often 
medicines need to be administered.6 A 
classical example of a problematic drug 
for administration via an enteral feeding 
tube is phenytoin.  Phenytoin absorption 
may be impaired both due to interaction 
with the enteral feed and due to binding to 
the feeding tube.  An adequate approach 
needs to be planned out depending on 
the frequency of the dose which needs to 
be timed in between feeds.  Usually a 2 
hour feed-free period is required before 
and after phenytoin liquid administration.  
Appropriate monitoring is important to 
check the blood levels of phenytoin and 
especially when any changes are being 
made both with the drug and the feed.  
Such interactions need to be noticed and 
followed up. If doses were adjusted due 
to lack of therapeutic response, toxicity 
may ensue when feeds are discontinued (or 
changed to oral or parenteral), particularly 
in drugs with a narrow therapeutic index6 
such as phenytoin.  Adding medicines to 
the enteral feed is never recommended due 
to possibility of microbial contamination 
and lack of information on interactions and 
stability.6
Besides interactions related with feeds, 
interactions are also possible with tap water 
although this has been rarely reported.  
Drugs such as ciprofloxacin and doxazocin, 
may chelate with the ions in tap water used 
to administer the drug.   In these cases 
deionized water should be used.6
Other	issues	related	
to	feeding	tubes
The type, size and placement of tube 
is an important factor which may influence 
the administration of the drug eg. fine 
bores are unsuitable for thick liquids.  The 
site of placement of the tube should be 
noted before administering a drug to avoid 
a situation where the placement may extend 
beyond the main site of absorption of the 
drug.  Drugs that may be affected by this 
include cephalexin, ketoconazole; and 
also drugs that have a narrow therapeutic 
window eg. digoxin, warfarin, theophylline, 
carbamazepine, sodium valproate, 
phenytoin, and other anticonvulsants.6,7,13  
It is necessary to monitor the patient for 
signs of reduction in efficacy of these 
medicines.
• Try to use an alternative route to the oral route.
• If no alternative exists, use dispersible tablets or liquid (caution with syrups)
• If a tablet or capsule has to be used, consider the properties of the formulation 
• Time the medicines administration in between feeds to avoid drug-feed interaction
• Correct flushing techniques are important to avoid blockage of tube 
Practice	Points	for	administering	medicines	via	an	enteral	feeding	tube
Blockage of the tube occurs when the 
precautions mentioned above are not taken 
into consideration.  It is important to 
take precautions as well as assessing the 
possibility that a particular drug may cause 
obstructions such as bulk forming medicines 
(laxatives) as well as sucralfate.  The drugs 
must be administered separately.  A correct 
administration technique is required with 
adequate flushing between drugs to avoid 
blockage which must be recorded especially 
in cases of fluid restriction.  
Conclusion
Administering drugs through this route 
requires trained and experienced healthcare 
professionals due to the highly specialized 
area.  Each drug must be analysed as to 
the best possible way to be administered 
without tampering with its properties.  If the 
oral dosage form is being used differently 
than the manufacturer intended it, then the 
responsibility lies with the prescriber and 
must be aware that this is an unlicensed use. 
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